NEUROTECH INTERNATIONAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.075 AUD | +1.35% |
|
-17.58% | +8.70% |
| 04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
| 04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 0.0910 | 0.1200 | 0.1200 |
| Spread/Res. | -17.58% | -37.50% | -37.50% |
| Spread/Supp. | +2.74% | +44.23% | +22.95% |
| Support | 0.0730 | 0.0520 | 0.0610 |
- Stock Market
- Equities
- NTI Stock
- Charts Neurotech International Limited
